Viewing StudyNCT00202800



Ignite Creation Date: 2024-05-05 @ 12:00 PM
Last Modification Date: 2024-10-26 @ 9:18 AM
Study NCT ID: NCT00202800
Status: COMPLETED
Last Update Posted: 2023-06-02
First Post: 2005-09-12

Brief Title: Phase II Trial to Evaluate Gemcitabine and Etoposide for Locally Advanced or Metastatic Pancreatic Cancer
Sponsor: Spectrum Health Hospitals
Organization: Spectrum Health Hospitals

Conditions & Keywords Data

Conditions:
Name
Pancreatic Cancer
Keywords:
Name View
Ras-mutation View
Pancreatic Cancer View
GemcitabineEtoposide View